​Dr.Sasmita Vadgaonkar is the Best Surgical Oncologist in Mumbai, Oncologist in Mumbai, Oncosurgeon in Vile Parle,Mumbai. Dr.Sasmita Vadgaonkar is a highly skilled Consultant in Surgical Oncology with over 12 years of experience. Dr.Sasmita is specialized in advanced surgeries in Gastrointestinal, Hepatopancreatic biliary, Gynaecological, Urological, Cytoreductive surgeries, HIPEC, PIPAC, Head neck and Breast cancers. She has been trained in managing and treating complex Gastrointestinal, Hepato pancreatic biliary cancer cases, minimally invasive Laparoscopic and Robotic surgeries. She is certified for PIPAC under renowned experts Prof. Martin Hubner and Prof. Somshekhar at Aster Hospital, Bangalore and trained in CRS and HIPEC. Dr.Sasmita Vadgaonkar has completed her M.B.B.S and internship from MUHS (Maharashtra University of Health Science), Dr.VMGMC, Solapur before pursuing post graduation in General Surgery at Jehangir Hospital and Research Centre, Pune. There she refined her surgical skills and got trained in routine surgical cases and emergencies. Then she did her Doctorate in National Board of Surgical Oncology from Sir HN Reliance Foundation Hospital and Research centre where she got extensively trained in head neck cancers, Breast cancer, Gynaecological cancers, Soft tissue sarcoma, thoracic, Gastrointestinal and Hepato pancreatic biliary cancer surgeries. After the completion she did a 6 months post exclusively in the Breast Cancer unit at Sir HN Reliance Foundation Hospital and Research centre where she refined her skills in Breast surgeries, Oncoplasty and management of Breast Cancers. Then she got extensively trained in her primary focus of interest which is Gastrointestinal and Hepatopancreatic biliary cancer surgeries for 4years. She is an Intuitive certified Robotic Console Surgeon.

Dr.Sasmita Vadgaonkar is the Best Cancer Specialist in Mumbai, Cancer Doctor in Mumbai, Cancer Treatment Surgeon in Mumbai, Cancer Surgeon in Vile Parle,Mumbai. Cancer surgery involves physically removing cancerous tumors or growths from the body, and it can be used to diagnose, prevent, treat, or palliate cancer. The goal is to remove all cancer cells, often including surrounding healthy tissue and nearby lymph nodes, which may be performed using open surgery, minimally invasive techniques like laparoscopy, or robot-assisted surgery. While effective for early-stage cancers, surgery may also be part of a broader treatment plan that includes chemotherapy and radiation therapy. Types of Surgical Approaches------------- -Open Surgery: Involves a single, larger incision to access and remove the tumor. -Minimally Invasive Surgery: Utilizes small incisions, a tiny camera (laparoscope), and specialized instruments to perform the surgery. -Robot-Assisted Surgery: A type of minimally invasive surgery that uses a robotic system to enhance precision and visualization. -Cryosurgery: Destroys cancerous cells with extreme cold, often used for skin cancers or other surface tumors.

Dr.Sasmita Vadgaonkar is the Best Gastrointestinal Hepatobiliary and Pancreatic Cancers (Including Gastric Cancers, Colorectal Cancers, Peritoneal surface malignancies) Surgeon in Vile Parle,Mumbai. Gastrointestinal (GI) cancers refer to cancers that develop in the digestive system, affecting organs like the esophagus, stomach, small and large intestines, liver, and pancreas. Common types include colorectal, stomach, liver, esophageal, and pancreatic cancers, which collectively are a significant cause of cancer-related deaths globally. Early detection through screening tests like colonoscopies is crucial for successful treatment, and prevention involves a healthy lifestyle, regular physical activity, and avoiding tobacco and excessive alcohol consumption. Types of GI Cancers------------ -Colorectal cancer: Affects the colon and rectum. -Esophageal cancer: Occurs in the esophagus, with difficulty swallowing and heartburn as key signs. -Stomach (Gastric) cancer: Develops in the stomach, causing persistent heartburn and stomach pain. -Liver cancer: Can be intrahepatic (inside the liver) or extrahepatic (outside the liver). -Pancreatic cancer: Often associated with smoking and obesity. -Anal cancer: A less common type, linked to the HPV virus.

Dr.Sasmita Vadgaonkar is the Best Hepatopancreaticobiliary Cancers (Including Liver Cancers, Gall bladder Cancers, Cholangiocarcinoma, Pancreatic Cancer) Surgeon in Vile Parle,Mumbai. Hepatopancreatobiliary (HPB) cancers are a group of malignant tumors affecting the liver, pancreas, and bile ducts (including the gallbladder). These cancers are often challenging to diagnose and treat due to their aggressive nature and late-stage presentation, with key examples including hepatocellular carcinoma, pancreatic cancer, and cholangiocarcinoma (bile duct cancer). Treatment involves a multidisciplinary approach, combining surgery, chemotherapy, radiation therapy, and targeted therapies, and often requires specialized surgical expertise.

Dr.Sasmita Vadgaonkar is the Best Head Neck Cancers in Vile Parle,Mumbai. Head and neck cancers are a group of cancers originating in the tissues of the head and neck region, most commonly in the squamous cells lining the mouth, throat, and voice box. Key risk factors include tobacco and heavy alcohol use, and infection with high-risk human papillomavirus (HPV). Symptoms vary by cancer location but can include a persistent sore in the mouth that doesn't heal, difficulty swallowing, a lump in the neck, a hoarse voice, or unexplained bleeding. Treatment often involves a combination of surgery, radiation, and chemotherapy, and early detection significantly improves the chance of a cure. What Head and Neck Cancers Are----------- -This term describes cancers that start in the head and neck area. -Most are squamous cell carcinomas, meaning they begin in the thin, flat cells lining the moist surfaces of the mouth, throat (pharynx), and voice box (larynx). -Other, less common types can arise from the salivary glands, nasal cavity, and paranasal sinuses.

Dr.Sasmita Vadgaonkar is the Best Gynaecological Cancer Surgeon in Mumbai, Gynaecological Cancer Specialist in Vile Parle,Mumbai. Gynaecological cancers are cancers that affect a woman's reproductive organs, including the five primary types: cervical, ovarian, uterine (also called endometrial), vaginal, and vulvar cancers. They can also be defined as any cancer that begins in a woman's reproductive organs. A sixth, very rare type, is fallopian tube cancer. Symptoms can be vague and vary by type, but early detection and treatment offer a better prognosis. Types of Gynaecological Cancers---------- -Cervical cancer: Cancer of the cervix, the lower, narrow part of the uterus that opens into the vagina. It is often caused by the human papillomavirus (HPV). -Ovarian cancer: Cancer of the ovaries. -Uterine cancer: Cancer of the uterus, most commonly originating in the endometrium, the lining of the uterus. -Vaginal cancer: Cancer of the vagina. -Vulvar cancer: Cancer of the vulva, the external female genitals. -Fallopian tube cancer: A rare type of cancer that starts in the fallopian tubes.

Dr.Sasmita Vadgaonkar is the Best Breast Cancer Surgeon in Mumbai, Breast Cancer Specialist in Vile Parle,Mumbai. Breast cancer is a malignant tumor that forms from breast tissue, often appearing as a lump, but also causing skin changes like dimpling, nipple changes, or discharge. Risk factors include increasing age, family history, obesity, and prior radiation exposure, though it can also occur in women without known risk factors. Treatment varies by type and stage but often involves surgery, radiation, chemotherapy, or hormone therapy, and early detection through screening is crucial for a better prognosis. What It Is--------------------- -Breast cancer occurs when cells in the breast grow and divide uncontrollably, forming a mass or tumor. -These cancerous cells can spread, or metastasize, to other parts of the body through the blood and lymph systems.

Dr.Sasmita Vadgaonkar is the Best Urological Cancer Surgeon in Vile Parle,Mumbai. Urological cancers affect the urinary system, which includes the bladder, kidneys, and ureters, and the male reproductive system, such as the prostate and testes. Common types are prostate, bladder, and kidney cancer, though urethral cancer also occurs. Early detection through regular screenings is critical for successful treatment outcomes. Types of Urological Cancers------------- -Prostate Cancer: Cancer of the prostate gland, a gland vital for male reproductive health. -Bladder Cancer: Occurs in the bladder, which stores urine, and is more common in older adults. -Kidney Cancer (Renal Cancer): Cancer that originates in the kidneys. -Testicular Cancer: Cancer of the testicles, often highly treatable, especially when caught early. -Urethral Cancer: Cancer of the urethra, the tube that carries urine out of the body.

Retroperitoneal sarcomas (RPS) are rare, slow-growing cancers originating from connective tissues in the back of the abdomen that can become large before symptoms appear. Common types include liposarcomas (from fatty tissue) and leiomyosarcomas (from muscle), with diagnosis involving imaging (like CT scans) and a tissue biopsy. The primary treatment is aggressive surgery, though recurrence is common and new therapies are being explored, with prognosis depending on tumor type, grade, and surgical success.

Neuroendocrine neoplasms (NENs) are tumors that arise from neuroendocrine cells throughout the body, most commonly in the gastrointestinal (GI) tract, lungs, and pancreas. They are categorized as either slow-growing well-differentiated neuroendocrine tumors (NETs) or aggressive, poorly differentiated neuroendocrine carcinomas (NECs). Diagnosis involves imaging and biochemical tests, with histology confirming the type and grade. Treatments vary depending on the tumor's specific type, grade, and location but may include surgery, targeted therapies, peptide receptor radionuclide therapy (PRRT), and other drug treatments.

Gastrointestinal stromal tumors (GISTs) are rare soft tissue sarcomas that grow from specialized cells in the GI tract wall called interstitial cells of Cajal. Most GISTs occur in the stomach or small intestine and can range from small, benign tumors to large, malignant ones that can spread. Symptoms include abdominal pain, blood in the stool or vomit, and fatigue, though smaller GISTs may be asymptomatic. Treatment for GISTs typically involves surgery and targeted therapies, with factors like tumor size and genetic mutations influencing prognosis and treatment choices.

Chemoport insertion is a surgical procedure to place an implantable device under the skin, usually on the chest, to provide long-term, reliable access to a major blood vessel for administering chemotherapy, drawing blood, and other medical treatments. The procedure minimizes the discomfort and potential vein damage from frequent needle sticks, offers safety by preventing medication leakage (extravasation), and allows for more convenient and hassle-free treatment. The procedure is performed under local or general anesthesia, and the device, also known as a port-a-cath, can be used for up to two years with proper care.

Robotic cancer surgery is a minimally invasive technique where a surgeon uses a robotic system, like the da Vinci Surgical System, to operate with enhanced precision and control, particularly in difficult-to-reach areas. This method involves small incisions, a high-definition 3D view, and instruments that mimic a surgeon's wrist movements, allowing for greater dexterity and accuracy. Benefits include reduced recovery times, shorter hospital stays, less blood loss, and improved outcomes for various cancers, such as prostate, colorectal, and head and neck cancers.

Minimally invasive laparoscopic surgery is a modern technique where surgeons perform procedures through small incisions, typically 0.5 to 1.5 cm, using a laparoscope (a thin tube with a camera) and other specialized instruments to view and operate on internal organs on a monitor. This approach offers significant advantages over traditional open surgery, including less pain, smaller scars, reduced infection risk, shorter hospital stays, and faster recovery times, making it a popular choice for various procedures in specialties like gastrointestinal, gynecological, and urological surgery.

Soft tissue sarcomas are rare cancers that begin in the body's soft tissues, such as muscle, fat, blood vessels, and nerves. Symptoms often include a new or growing lump or swelling, although deeper sarcomas may cause pain, abdominal issues, or other symptoms only when they press on nerves or organs. Diagnosis involves imaging and a biopsy, and treatment options depend on the specific type and location of the sarcoma and can include surgery, radiation, and chemotherapy.

Cytoreductive Surgery (CRS) is an extensive surgical procedure to remove all visible cancerous tumors from the abdominal cavity, often combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to kill remaining microscopic cells. This complex treatment is used for cancers, such as ovarian, gastric, colorectal, and appendiceal cancers, that have spread to the peritoneum (the lining of the abdomen). The goal is to achieve a complete removal of the cancer (CC-0 resection) to improve survival and reduce recurrence.

HIPEC (Hyperthermic Intraperitoneal Chemotherapy) surgery is a two-part cancer treatment for advanced abdominal cancers, where a surgeon first removes visible tumors (cytoreductive surgery) and then washes the abdomen with heated chemotherapy drugs to kill any remaining cancer cells. This technique delivers high-dose chemotherapy directly to the peritoneal cavity, offering greater drug absorption and effect with fewer side effects than traditional systemic chemotherapy. It is commonly used for cancers like appendiceal, colorectal, stomach, ovarian, and primary peritoneal mesothelioma.

PIPAC surgery, or Pressurized Intraperitoneal Aerosol Chemotherapy, is a minimally invasive laparoscopic procedure that delivers chemotherapy as a high-pressure aerosol directly into the abdominal cavity to treat peritoneal metastases from cancers like ovarian, stomach, pancreas, and colorectal cancer. This technique improves chemotherapy distribution and deeper tissue penetration while using lower doses, leading to fewer systemic side effects compared to traditional chemotherapy. The procedure is typically performed on an outpatient or daycare basis with a short hospital stay and can be repeated every 6-8 weeks for palliative care or to shrink tumors for subsequent treatments.